hit counter
USA Life Sciences Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

SCYNEXIS Issues a Voluntary Nationwide Recall of BREXAFEMME® (ibrexafungerp tablets) due to potential for cross contamination with a non-antibacterial ß-lactam drug substance

Read more ››
By: GlobeNewswire - 28 Sep 2023
Related companies:  SCYNEXIS, Inc

BioCity Signs Collaboration Agreement with AstraZeneca on BC3402, a monoclonal antibody targeting anti-TIM-3, in Combination with IMFINZI (durvalumab) for the Treatment of Advanced Hepatocellular Carcinoma in China

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023

Base Pair Bio Receives Grant from NIH to Help Deliver Therapies for Genetic Heart Disease

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  Base Pair Biotechnologies, Inc

Akeso Announced FDA Clearance of IND for CD47 Monoclonal Antibody (AK117) in Combination with Azacitidine in Myelodysplastic Syndromes

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  Akeso Biomedical, Inc. | Akeso Ventures Inc

BrainStorm Cell Therapeutics Provides Update on FDA Advisory Committee Meeting to Review NurOwn for the Treatment of ALS

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  BrainStorm Cell Therapeutics Inc.

Capita3 Announces Acquisition of Portfolio Company EmpowerU by FullBloom to Help Young People Thrive in Academics and Life

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023

MediciNova Announces Results of Studies under BARDA Contract to Develop MN 166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury

Read more ››
By: GlobeNewswire - 28 Sep 2023
Related companies:  MediciNova, Inc.

Ocugen to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference

Read more ››
By: GlobeNewswire - 28 Sep 2023
Related companies:  Ocugen, Inc.

Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 Million

Read more ››
By: PR Newswire Association LLC. - 28 Sep 2023
Related companies:  Inovio Pharmaceuticals, Inc.

Acuitive Technologies Receives FDA 510(k) Clearance for CITRELOCK DUO a New Sports Medicine Fixation Device for Biceps Tenodesis and Tendon Transfer Procedures

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Acuitive Technologies Inc.

Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Iovance Biotherapeutics, Inc.

Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Gritstone bio

Soleno Therapeutics Announces Proposed Public Offering of Common Stock and/or Pre-Funded Warrants and a Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Soleno Therapeutics, Inc.

Sagimet Biosciences Announces Completion of Enrollment of 120 Patients for Phase 3 Clinical Trial by Its Partner Ascletis of Denifanstat Combined with Bevacizumab for Treatment of Recurrent Glioblastoma

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Sagimet Biosciences

Option Care Health to Announce Third Quarter 2023 Financial Results and Host Conference Call

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Option Care Health Inc.

23andMe Announces Poster Presentations on 23ME-00610, an Investigational Antibody Targeting CD200R1, at The Society for Immunotherapy of Cancer’s (SITC) 2023 Annual Meeting

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  23andMe, Inc.

Praxis Precision Medicines To Host Hybrid R&D Day on Monday, October 2, 2023

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Praxis Precision Medicines, Inc.

Supernus Pharmaceuticals Announces Webcast of R&D Day to be Held on October 18, 2023 in New York City

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Supernus Pharmaceuticals, Inc.

PepGen Announces Upcoming Presentations at the 28th Annual Congress of the World Muscle Society and the World Congress of Neurology

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  PepGen Inc.

Cellectis to Present Pre-Clinical Data on Multi-armored Allogeneic MUC1-CAR T-cells Targeting Triple-Negative Breast Cancer at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Read more ››
By: GlobeNewswire - 27 Sep 2023
Related companies:  Cellectis Inc.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Looking for companies outside of the United States?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • September 2023
    • Barcelona: BioSpain 2023
  • October 2023
    • New York City: BioFuture
    • BioJapan
See Events »
Add an Event »

Latest company news

SCYNEXIS Issues a Voluntary Nationwide Recall of BREXAFEMME® (ibrexafungerp tablets) due to potential for cross contamination with a non-antibacterial ß-lactam drug substance
28 Sep 2023 (GlobeNewswire)

BioCity Signs Collaboration Agreement with AstraZeneca on BC3402, a monoclonal antibody targeting anti-TIM-3, in Combination with IMFINZI (durvalumab) for the Treatment of Advanced Hepatocellular Carcinoma in China
28 Sep 2023 (PR Newswire Association LLC.)

Base Pair Bio Receives Grant from NIH to Help Deliver Therapies for Genetic Heart Disease
28 Sep 2023 (PR Newswire Association LLC.)

Biotechgate database

About Biotechgate
The USA Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com